{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T16:46:23Z","timestamp":1790527583542,"version":"4.1.0"},"reference-count":54,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2018,11,30]],"date-time":"2018-11-30T00:00:00Z","timestamp":1543536000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["2P20GM103548"],"award-info":[{"award-number":["2P20GM103548"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["5P20GM103620"],"award-info":[{"award-number":["5P20GM103620"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Tumor cell metabolism differs from that of normal cells, conferring tumors with metabolic advantages but affording opportunities for therapeutic intervention. Accordingly, metabolism-targeting therapies have shown promise. However, drugs targeting singular metabolic pathways display limited efficacy, in part due to the tumor\u2019s ability to compensate by using other metabolic pathways to meet energy and growth demands. Thus, it is critical to identify novel combinations of metabolism-targeting drugs to improve therapeutic efficacy in the face of compensatory cellular response mechanisms. Our lab has previously identified that the anti-cancer activity of propranolol, a non-selective beta-blocker, is associated with inhibition of mitochondrial metabolism in head and neck squamous cell carcinoma (HNSCC). In response to propranolol, however, HNSCC exhibits heightened glycolytic activity, which may limit the effectiveness of propranolol as a single agent. Thus, we hypothesized that propranolol\u2019s metabolic effects promote a state of enhanced glucose dependence, and that propranolol together with glycolytic inhibition would provide a highly effective therapeutic combination in HNSCC. Here, we show that glucose deprivation synergizes with propranolol for anti-cancer activity, and that the rational combination of propranolol and dichloroacetate (DCA), a clinically available glycolytic inhibitor, dramatically attenuates tumor cell metabolism and mTOR signaling, inhibits proliferation and colony formation, and induces apoptosis. This therapeutic combination displays efficacy in both human papillomavirus-positive (HPV(+)) and HPV(\u2212) HNSCC cell lines, as well as a recurrent\/metastatic model, while leaving normal tonsil epithelial cells relatively unaffected. Importantly, the combination significantly delays tumor growth in vivo with no evidence of toxicity. Additionally, the combination of propranolol and DCA enhances the effects of chemoradiation and sensitizes resistant cells to cisplatin and radiation. This novel therapeutic combination represents a promising treatment strategy which may overcome some of the limitations of targeting individual metabolic pathways in cancer.<\/jats:p>","DOI":"10.3390\/cancers10120476","type":"journal-article","created":{"date-parts":[[2018,11,30]],"date-time":"2018-11-30T12:13:17Z","timestamp":1543579997000},"page":"476","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Propranolol Promotes Glucose Dependence and Synergizes with Dichloroacetate for Anti-Cancer Activity in HNSCC"],"prefix":"10.3390","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1669-0611","authenticated-orcid":false,"given":"Christopher","family":"Lucido","sequence":"first","affiliation":[{"name":"Cancer Biology and Immunotherapies Group, Sanford Research, 2301 East 60th St North, Sioux Falls, SD 57104, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Miskimins","sequence":"additional","affiliation":[{"name":"Cancer Biology and Immunotherapies Group, Sanford Research, 2301 East 60th St North, Sioux Falls, SD 57104, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Vermeer","sequence":"additional","affiliation":[{"name":"Cancer Biology and Immunotherapies Group, Sanford Research, 2301 East 60th St North, Sioux Falls, SD 57104, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2018,11,30]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1016\/S0140-6736(08)60728-X","article-title":"Head and neck cancer","volume":"371","author":"Argiris","year":"2008","journal-title":"The Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3322\/caac.21262","article-title":"Global cancer statistics, 2012","volume":"65","author":"Torre","year":"2015","journal-title":"CA Cancer J. Clin."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21387","article-title":"Cancer Statistics, 2017","volume":"67","author":"Siegel","year":"2017","journal-title":"CA Cancer J. Clin."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.mayocp.2015.12.017","article-title":"Head and Neck Squamous Cell Carcinoma: Update on Epidemiology, Diagnosis, and Treatment","volume":"91","author":"Marur","year":"2016","journal-title":"Mayo. Clin. Proc."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/jnci\/djn011","article-title":"Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial","volume":"100","author":"Fakhry","year":"2008","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"3305","DOI":"10.1200\/JCO.2015.62.0963","article-title":"Current Treatment Options for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma","volume":"33","author":"Sacco","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1038\/sj.bjc.6602510","article-title":"State-of-the-art management of locally advanced head and neck cancer","volume":"92","author":"Seiwert","year":"2005","journal-title":"Br. J. Cancer"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.bbi.2010.12.012","article-title":"Stress hormones increase cell proliferation and regulates interleukin-6 secretion in human oral squamous cell carcinoma cells","volume":"25","author":"Bernabe","year":"2011","journal-title":"Brain Behav. Immun."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/jcp.25092","article-title":"Selective beta2-AR Blockage Suppresses Colorectal Cancer Growth Through Regulation of EGFR-Akt\/ERK1\/2 Signaling, G1-Phase Arrest, and Apoptosis","volume":"231","author":"Chin","year":"2016","journal-title":"J. Cell. Physiol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"3135","DOI":"10.3892\/or.2016.4710","article-title":"Inhibition of beta2-adrenergic receptor reduces triple-negative breast cancer brain metastases: The potential benefit of perioperative beta-blockade","volume":"35","author":"Choy","year":"2016","journal-title":"Oncol. Rep."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.3892\/or.2015.3874","article-title":"Antiproliferative effects of beta-blockers on human colorectal cancer cells","volume":"33","author":"Coelho","year":"2015","journal-title":"Oncol. Rep."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1600-0714.2008.00691.x","article-title":"Expression of beta2-adrenergic receptor in oral squamous cell carcinoma","volume":"38","author":"Shang","year":"2009","journal-title":"J. Oral Pathol. Med."},{"key":"ref_13","first-page":"334","article-title":"Propranolol as a Novel Adjunctive Treatment for Head and Neck Squamous Cell Carcinoma","volume":"41","author":"Wolter","year":"2012","journal-title":"Otolaryngol. Head Neck Surg."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Zhang, D., Ma, Q., Wang, Z., Zhang, M., Guo, K., Wang, F., and Wu, E. (2011). Beta2-adrenoceptor blockage induces G1\/S phase arrest and apoptosis in pancreatic cancer cells via Ras\/Akt\/NF B pathway. Mo. Cancer, 10.","DOI":"10.1186\/1476-4598-10-146"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"19","DOI":"10.4161\/cbt.10.1.11944","article-title":"\u03b22-adrenergic antagonists suppress pancreatic cancer cell invasion by inhibiting CREB, NF-\u03baB and AP-1","volume":"10","author":"Zhang","year":"2014","journal-title":"Cancer Biol. Ther."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"3444","DOI":"10.1002\/cncr.29392","article-title":"Clinical impact of selective and nonselective beta-blockers on survival in patients with ovarian cancer","volume":"121","author":"Watkins","year":"2015","journal-title":"Cancer"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"628","DOI":"10.18632\/oncotarget.197","article-title":"Beta-Blocker Drug Therapy Reduces Secondary Cancer Formation in Breast Cancer and Improves Cancer Specific Survival","volume":"1","author":"Powe","year":"2010","journal-title":"Oncotarget"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"De Giorgi, V., Grazzini, M., Benemei, S., Marchionni, N., Botteri, E., Pennacchioli, E., Geppetti, P., and Gandini, S. (2017). Propranolol for Off-Label Treatment of Patients With Melanoma: Results From a Cohort Study. JAMA Oncol.","DOI":"10.1001\/jamaoncol.2017.2908"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/s41389-018-0090-2","article-title":"Beta2-Adrenergic receptor modulates mitochondrial metabolism and disease progression in recurrent\/metastatic HPV(+) HNSCC","volume":"7","author":"Lucido","year":"2018","journal-title":"Oncogenesis"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Jia, D., Park, J.H., Jung, K.H., Levine, H., and Kaipparettu, B.A. (2018). Elucidating the Metabolic Plasticity of Cancer: Mitochondrial Reprogramming and Hybrid Metabolic States. Cells, 7.","DOI":"10.3390\/cells7030021"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.redox.2017.04.018","article-title":"Teaching the basics of cancer metabolism: Developing antitumor strategies by exploiting the differences between normal and cancer cell metabolism","volume":"12","author":"Kalyanaraman","year":"2017","journal-title":"Redox. Biol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1097\/PPO.0000000000000099","article-title":"Novel therapeutic targets of tumor metabolism","volume":"21","author":"Kishton","year":"2015","journal-title":"Cancer J."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"148","DOI":"10.4331\/wjbc.v6.i3.148","article-title":"Metabolic interplay between glycolysis and mitochondrial oxidation: The reverse Warburg effect and its therapeutic implication","volume":"6","author":"Lee","year":"2015","journal-title":"World J. Biol. Chem."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"3960","DOI":"10.1038\/onc.2009.251","article-title":"Impaired PTPN13 phosphatase activity in spontaneous or HPV-induced squamous cell carcinomas potentiates oncogene signaling through the MAP kinase pathway","volume":"28","author":"Hoover","year":"2009","journal-title":"Oncogene"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1128\/JVI.02188-07","article-title":"The PDZ binding motif of human papillomavirus type 16 E6 induces PTPN13 loss, which allows anchorage-independent growth and synergizes with ras for invasive growth","volume":"82","author":"Spanos","year":"2008","journal-title":"J. Virol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1001\/archoto.2009.159","article-title":"Immune Response During Therapy With Cisplatin or Radiation for Human Papillomavirus-Related Head and Neck Cancer","volume":"135","author":"Spanos","year":"2009","journal-title":"Arch. Otolaryngol. Head Neck Surg."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1002\/hed.21040","article-title":"Preclinical models of HPV+ and HPV- HNSCC in mice: An immune clearance of HPV+ HNSCC","volume":"31","author":"Williams","year":"2009","journal-title":"Head Neck"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"24194","DOI":"10.18632\/oncotarget.8254","article-title":"Metastatic model of HPV+ oropharyngeal squamous cell carcinoma demonstrates heterogeneity in tumor metastasis","volume":"7","author":"Vermeer","year":"2016","journal-title":"Oncotarget"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"e219","DOI":"10.1038\/emm.2016.6","article-title":"Pancreatic regulation of glucose homeostasis","volume":"48","author":"Roder","year":"2016","journal-title":"Exp. Mol. Med."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1038\/sj.bjc.6604554","article-title":"Dichloroacetate (DCA) as a potential metabolic-targeting therapy for cancer","volume":"99","author":"Michelakis","year":"2008","journal-title":"Br. J. Cancer"},{"key":"ref_31","first-page":"617","article-title":"Dichloroacetate and cancer: New home for an orphan drug?","volume":"1846","author":"Kankotia","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"24228","DOI":"10.18632\/oncotarget.8286","article-title":"mTOR inhibition as an adjuvant therapy in a metastatic model of HPV+ HNSCC","volume":"7","author":"Coppock","year":"2016","journal-title":"Oncotarget"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1593\/neo.13432","article-title":"Improved Clearance during Treatment of HPV-Positive Head and Neck Cancer through mTOR Inhibition","volume":"15","author":"Coppock","year":"2013","journal-title":"Neoplasia"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/hed.21664","article-title":"Altered metabolism in head and neck squamous cell carcinoma: An opportunity for identification of novel biomarkers and drug targets","volume":"34","author":"Sandulache","year":"2012","journal-title":"Head Neck"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"711","DOI":"10.3109\/0284186X.2012.731524","article-title":"Weight loss in patients with head and neck cancer during and after conventional and accelerated radiotherapy","volume":"52","author":"Ottosson","year":"2013","journal-title":"Acta Oncol."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Hager, K.K. (2016). Management of Weight Loss in People With Cancer. J. Adv. Pract. Oncol., 7.","DOI":"10.6004\/jadpro.2016.7.3.19"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1093\/annonc\/mdw211","article-title":"Relationship between efficacy outcomes and weight gain during treatment of advanced, non-squamous, non-small-cell lung cancer patients","volume":"27","author":"Patel","year":"2016","journal-title":"Ann. Oncol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"152","DOI":"10.21037\/atm.2017.03.20","article-title":"Practical and theoretical implications of weight gain in advanced non-small cell lung cancer patients","volume":"5","author":"Bonomi","year":"2017","journal-title":"Ann. Transl. Med."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: The next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.ccr.2008.05.005","article-title":"Tumor cell metabolism: Cancer\u2019s Achilles\u2019 heel","volume":"13","author":"Kroemer","year":"2008","journal-title":"Cancer Cell."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1126\/science.1160809","article-title":"Understanding the Warburg effect: The metabolic requirements of cell proliferation","volume":"324","author":"Cantley","year":"2009","journal-title":"Science"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/cr.2017.155","article-title":"Mitochondrial metabolism and cancer","volume":"28","author":"Porporato","year":"2017","journal-title":"Cell. Res."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/nchembio.1712","article-title":"Targeting mitochondria metabolism for cancer therapy","volume":"11","author":"Weinberg","year":"2015","journal-title":"Nat. Chem. Biol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.cmet.2017.04.004","article-title":"Autophagy and Tumor Metabolism","volume":"25","author":"Kimmelman","year":"2017","journal-title":"Cell. Metab."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"e302","DOI":"10.1016\/S1470-2045(13)70085-8","article-title":"Novel targets in HPV-negative head and neck cancer: Overcoming resistance to EGFR inhibition","volume":"14","author":"Burtness","year":"2013","journal-title":"The Lancet Oncol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"363","DOI":"10.2147\/CMAR.S115761","article-title":"Head and neck cancer: Improving outcomes with a multidisciplinary approach","volume":"9","author":"Denaro","year":"2017","journal-title":"Cancer Manag. Res."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.hoc.2008.08.007","article-title":"Molecular biology of head and neck cancer: Risks and pathways","volume":"22","author":"Stadler","year":"2008","journal-title":"Hematol. Oncol. Clin. North. Am."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Sever, R., and Brugge, J.S. (2015). Signal transduction in cancer. Cold Spring Harb. Perspect. Med., 5.","DOI":"10.1101\/cshperspect.a006098"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"5232","DOI":"10.1021\/pr200800w","article-title":"Magic angle spinning NMR-based metabolic profiling of head and neck squamous cell carcinoma tissues","volume":"10","author":"Somashekar","year":"2011","journal-title":"J. Proteome Res."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1016\/j.biocel.2012.06.025","article-title":"Delineating metabolic signatures of head and neck squamous cell carcinoma: Phospholipase A2, a potential therapeutic target","volume":"44","author":"Tripathi","year":"2012","journal-title":"Int. J. Biochem. Cell. Biol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"7050","DOI":"10.1038\/s41598-018-25340-9","article-title":"Propranolol sensitizes prostate cancer cells to glucose metabolism inhibition and prevents cancer progression","volume":"8","author":"Brohee","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_52","first-page":"680","article-title":"Repurposing Drugs in Oncology (ReDO)-Propranolol as an anti-cancer agent","volume":"10","author":"Pantziarka","year":"2016","journal-title":"Ecancermedicalscience"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/hed.21198","article-title":"Genotyping of 73 UM-SCC head and neck squamous cell carcinoma cell lines","volume":"32","author":"Brenner","year":"2010","journal-title":"Head Neck"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1001\/archotol.133.5.495","article-title":"The role of human papillomavirus 16 E6 in anchorage-independent and invasive growth of mouse tonsil epithelium","volume":"133","author":"Hoover","year":"2007","journal-title":"Arch. Otolaryngol. Head Neck Surg."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/10\/12\/476\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T15:33:32Z","timestamp":1760196812000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/10\/12\/476"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,30]]},"references-count":54,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["cancers10120476"],"URL":"https:\/\/doi.org\/10.3390\/cancers10120476","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,30]]}}}